Semax (ACTH Fragment Peptide)

Is Semax Really an ACTH(4-10) Analogue?

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

Semax is conventionally described as an ACTH(4-10) analogue, and peer-reviewed papers use that phrase. Structurally it shares only residues 4 to 7 with ACTH (Met-Glu-His-Phe), with Pro-Gly-Pro replacing rather than modifying Arg-Trp-Gly. PubChem indexes it as ACTH(4-7)-PGP.

Key facts

ACTH(4-10) sequence
Met-Glu-His-Phe-Arg-Trp-Gly
Semax sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Shared with ACTH
Residues 4-7 only
Replaced
Arg-Trp-Gly → Pro-Gly-Pro
PubChem indexing
ACTH (4-7), Pro-Gly-Pro-
Consequence
No steroidogenic activity

Line the two sequences up

ACTH residues 4 through 10 are Met-Glu-His-Phe-Arg-Trp-Gly. Semax is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues are identical. The last three are entirely different. They are not conservative substitutions but a replacement of arginine, tryptophan and glycine with a proline-glycine-proline motif. Both peptides are seven residues long, which is part of why the ACTH(4-10) description became conventional.

Why the conventional name persists

It is not an error so much as a shorthand describing lineage rather than composition. Semax was designed from the ACTH(4-10) region, and papers including the 2006 Brain Research study on BDNF and trkB expression carry 'an analog of ACTH(4-10)' in their titles. PubChem, which indexes by structure rather than design history, records it as ACTH(4-7) plus Pro-Gly-Pro. Both descriptions are in legitimate use.

Research material referenced

Semax 10mg, third-party HPLC tested

Buy Semax · £24.99

Why the distinction actually matters

Because the substituted residues are the functionally important ones. The Arg-Trp-Gly segment contributes to ACTH's melanocortin-receptor pharmacology and its adrenal-stimulating activity. Removing it is not incidental tidying. It is the deliberate step that yields a peptide retaining reported central activity without stimulating adrenal steroidogenesis. Describing Semax as an ACTH(4-10) analogue and stopping there obscures the single most consequential design decision in the molecule.

What Pro-Gly-Pro brings in its place

Proline-containing motifs resist most peptidases, because the ring structure constrains the backbone conformation that proteolytic enzymes require at their active site. Substituting a protease-vulnerable tripeptide with a proline-rich one raises stability substantially. So the same change that removes an unwanted activity also solves a durability problem, which is an unusually economical piece of design.

How to describe it accurately

The accurate short description is that Semax is a heptapeptide comprising the ACTH(4-7) fragment with a C-terminal Pro-Gly-Pro extension. If reading a paper that says ACTH(4-10) analogue, nothing is wrong, but the reader should know the two peptides diverge after residue four.

Quick reference

PositionACTH(4-10)Semax
1 (ACTH 4)MetMet
2 (ACTH 5)GluGlu
3 (ACTH 6)HisHis
4 (ACTH 7)PhePhe
5ArgPro
6TrpGly
7GlyPro

Frequently asked questions

So is 'ACTH(4-10) analogue' wrong?

Not wrong, but imprecise. It describes design lineage. Structurally Semax shares only residues 4-7 with ACTH.

Why does Semax not stimulate the adrenals?

The Arg-Trp-Gly segment that contributes to that activity is not present. Pro-Gly-Pro replaces it.

Does the literature use both names?

Yes. Paper titles commonly say ACTH(4-10) analogue; PubChem indexes the structure as ACTH(4-7)-PGP.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Semax (ACTH Fragment Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.